Total Payments
$32,461
2024 Payments
$1,660
Companies
57
Transactions
688
Medicare Patients
23,550
Medicare Billing
$3.8M
Payment Breakdown by Category
Other$15,098 (46.5%)
Food & Beverage$11,850 (36.5%)
Travel$4,962 (15.3%)
Consulting$360.00 (1.1%)
Education$190.55 (0.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $15,060 | 9 | 46.4% |
| Food and Beverage | $11,850 | 654 | 36.5% |
| Travel and Lodging | $4,962 | 14 | 15.3% |
| Consulting Fee | $360.00 | 1 | 1.1% |
| Education | $190.55 | 9 | 0.6% |
| Debt forgiveness | $38.13 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Esperion Therapeutics, Inc. | $15,602 | 38 | $0 (2023) |
| Medtronic Vascular, Inc. | $1,860 | 49 | $0 (2020) |
| Abbott Laboratories | $1,620 | 27 | $0 (2024) |
| Penumbra, Inc. | $1,489 | 24 | $0 (2024) |
| Medtronic, Inc. | $1,424 | 84 | $0 (2024) |
| Philips Electronics North America Corporation | $1,243 | 1 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $796.35 | 55 | $0 (2024) |
| BIOTRONIK INC. | $787.31 | 5 | $0 (2024) |
| PFIZER INC. | $781.16 | 49 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $718.81 | 42 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,660 | 104 | PFIZER INC. ($369.81) |
| 2023 | $1,375 | 75 | Medtronic, Inc. ($408.13) |
| 2022 | $6,377 | 87 | Esperion Therapeutics, Inc. ($5,236) |
| 2021 | $11,831 | 65 | Esperion Therapeutics, Inc. ($10,302) |
| 2020 | $1,385 | 86 | Medtronic Vascular, Inc. ($360.94) |
| 2019 | $4,798 | 100 | Penumbra, Inc. ($1,266) |
| 2018 | $3,270 | 77 | Philips Electronics North America Corporation ($1,243) |
| 2017 | $1,765 | 94 | Medtronic Vascular, Inc. ($362.03) |
All Payment Transactions
688 individual payment records from CMS Open Payments — Page 1 of 28
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Penumbra, Inc. | Penumbra System (Device) | Food and Beverage | Cash or cash equivalent | $21.00 | General |
| Category: Neurointervention | ||||||
| 12/18/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $23.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/16/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $18.12 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/12/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $29.45 | General |
| Category: Cardiology | ||||||
| 12/11/2024 | Medtronic, Inc. | SYMPLICITY G3 (Device) | Food and Beverage | In-kind items and services | $7.38 | General |
| Category: Renal Denervation System | ||||||
| 12/09/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $7.92 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/03/2024 | Philips North America LLC | (CK4) MCOT (Device) | Food and Beverage | Cash or cash equivalent | $14.54 | General |
| Category: Medical Device | ||||||
| 12/02/2024 | Chiesi USA, Inc. | KENGREAL (Drug) | Food and Beverage | Cash or cash equivalent | $28.21 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/25/2024 | Penumbra, Inc. | Indigo System (Device) | Food and Beverage | Cash or cash equivalent | $18.04 | General |
| Category: Peripheral Intervention | ||||||
| 11/21/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.38 | General |
| Category: DIABETES | ||||||
| 11/15/2024 | Medtronic, Inc. | SYMPLICITY G3 (Device) | Food and Beverage | In-kind items and services | $5.71 | General |
| Category: Renal Denervation System | ||||||
| 11/13/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $17.89 | General |
| Category: Cardiology | ||||||
| 11/12/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $12.59 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/08/2024 | Medtronic, Inc. | SYMPLICITY G3 (Device) | Food and Beverage | In-kind items and services | $5.70 | General |
| Category: Renal Denervation System | ||||||
| 11/04/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $23.79 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/29/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $20.82 | General |
| 10/28/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $17.06 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 10/25/2024 | Penumbra, Inc. | Penumbra System (Device) | Food and Beverage | Cash or cash equivalent | $24.73 | General |
| Category: Neurointervention | ||||||
| 10/17/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $22.60 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/14/2024 | Philips North America LLC | (CK4) MCOT (Device) | Food and Beverage | Cash or cash equivalent | $24.05 | General |
| Category: Medical Device | ||||||
| 09/27/2024 | Abbott Laboratories | AMPLATZER PICCOLO (Device) | Food and Beverage | In-kind items and services | $16.42 | General |
| Category: Structural Heart | ||||||
| 09/27/2024 | Penumbra, Inc. | Penumbra System (Device) | Food and Beverage | Cash or cash equivalent | $4.90 | General |
| Category: Neurointervention | ||||||
| 09/18/2024 | Medtronic, Inc. | SYMPLICITY G3 (Device) | Food and Beverage | In-kind items and services | $5.10 | General |
| Category: Renal Denervation System | ||||||
| 09/16/2024 | Impulse Dynamics (USA) Inc. | Optimizer (Device), Optimizer | Food and Beverage | Cash or cash equivalent | $91.27 | General |
| Category: Cardiovascular Device | ||||||
| 09/13/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $13.54 | General |
| Category: Cardiology/Vascular Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 60 | 6,128 | 9,970 | $2.7M | $951,542 |
| 2022 | 58 | 6,247 | 10,258 | $2.6M | $942,966 |
| 2021 | 66 | 6,045 | 10,265 | $2.8M | $956,407 |
| 2020 | 58 | 5,130 | 9,397 | $2.4M | $917,841 |
Total Patients
23,550
Total Services
39,890
Medicare Billing
$3.8M
Procedure Codes
271
All Medicare Procedures & Services
271 procedure records from CMS Medicare Utilization — Page 1 of 11
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 964 | 1,750 | $444,724 | $159,773 | 35.9% |
| 78431 | Nuclear medicine studies of blood flow in heart muscle at rest and with stress with concurrent ct scan | Office | 2023 | 70 | 71 | $401,988 | $148,511 | 36.9% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 444 | 461 | $176,153 | $64,902 | 36.8% |
| A9555 | Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | Office | 2023 | 88 | 176 | $88,710 | $54,967 | 62.0% |
| 92928 | Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | Facility | 2023 | 89 | 122 | $149,084 | $53,236 | 35.7% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 155 | 155 | $131,130 | $51,005 | 38.9% |
| 93229 | Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | Office | 2023 | 63 | 66 | $105,666 | $41,135 | 38.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 459 | 531 | $95,091 | $32,672 | 34.4% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 163 | 660 | $163,848 | $28,207 | 17.2% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2023 | 155 | 310 | $99,544 | $27,052 | 27.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 231 | 419 | $67,040 | $26,152 | 39.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 159 | 159 | $69,996 | $24,893 | 35.6% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 129 | 140 | $84,420 | $24,158 | 28.6% |
| 78492 | Nuclear medicine studies of blood flow in heart muscle at rest and with stress | Office | 2023 | 18 | 18 | $67,447 | $20,771 | 30.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 141 | 148 | $51,800 | $20,153 | 38.9% |
| 33208 | Insertion of pacemaker and upper and lower heart chamber electrode | Facility | 2023 | 33 | 33 | $35,508 | $13,925 | 39.2% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 247 | 250 | $34,530 | $12,453 | 36.1% |
| 78434 | Nuclear medicine study of heart muscle blood flow by pet | Office | 2023 | 87 | 88 | $40,620 | $12,221 | 30.1% |
| 93925 | Ultrasound of leg arteries or artery grafts | Office | 2023 | 54 | 60 | $27,900 | $10,947 | 39.2% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 75 | 80 | $29,760 | $10,631 | 35.7% |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | Office | 2023 | 55 | 343 | $47,952 | $9,073 | 18.9% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 57 | 88 | $21,120 | $8,059 | 38.2% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 120 | 348 | $20,865 | $7,500 | 35.9% |
| 93296 | Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | Office | 2023 | 155 | 452 | $19,418 | $7,126 | 36.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 586 | 671 | $19,476 | $6,853 | 35.2% |
About Dr. Brian Saluck, DO
Dr. Brian Saluck, DO is a Interventional Cardiology healthcare provider based in The Villages, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/31/2006. The National Provider Identifier (NPI) number assigned to this provider is 1295796902.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Brian Saluck, DO has received a total of $32,461 in payments from pharmaceutical and medical device companies, with $1,660 received in 2024. These payments were reported across 688 transactions from 57 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($15,060).
As a Medicare-enrolled provider, Saluck has provided services to 23,550 Medicare beneficiaries, totaling 39,890 services with total Medicare billing of $3.8M. Data is available for 4 years (2020–2023), covering 271 distinct procedure/service records.
Ad
Practice Information
- Specialty Interventional Cardiology
- Other Specialties Interventional Cardiology
- Location The Villages, FL
- Active Since 03/31/2006
- Last Updated 10/11/2023
- Taxonomy Code 207RI0011X
- Entity Type Individual
- NPI Number 1295796902
Products in Payments
- NEXLIZET (Drug) $15,242
- Image Guided Therapy Devices _ Coronary (Device) $1,243
- Indigo (Device) $1,231
- Micra (Device) $998.11
- Cardiac Mapping System (Device) $898.11
- ELIQUIS (Drug) $743.60
- ENTRESTO (Drug) $593.97
- BRILINTA (Drug) $555.65
- LifeVest (Device) $554.56
- XARELTO (Drug) $474.11
- Repatha (Biological) $462.34
- VYNDAQEL (Drug) $394.22
- NEXLETOL (Drug) $360.22
- Diamondback Coronary (Device) $360.00
- RESOLUTE ONYX (Device) $337.48
- VIABAHN Endoprosthesis (Device) $303.59
- Reveal LINQ (Device) $301.54
- Resolute (Device) $280.08
- PRALUENT (Drug) $217.32
- HawkOne (Device) $209.92
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Interventional Cardiology Doctors in The Villages
Vishnu Yelamanchi, Md, MD
Interventional Cardiology — Payments: $46,372
Interventional Cardiology $46,372
Dr. Hector Garcia, M.d, M.D
Interventional Cardiology — Payments: $38,727
Interventional Cardiology $38,727
Srinivas Attanti, Md, MD
Interventional Cardiology — Payments: $16,446
Interventional Cardiology $16,446
Dr. Abel Rivero, M.d, M.D
Interventional Cardiology — Payments: $9,935
Interventional Cardiology $9,935
Dr. Farshid Daneshvar, M.d, M.D
Interventional Cardiology — Payments: $2,981
Interventional Cardiology $2,981
Jaimie Chamberlin, Aprn, APRN
Interventional Cardiology — Payments: $1,396
Interventional Cardiology $1,396